Prostate cancer is one of the most common types of cancer among men worldwide. In fact, in the United States alone, it is estimated that there will be 191,930 new cases of prostate cancer in 2020.
Despite the pervasiveness of this disease, there are still many myths and misconceptions surrounding it. Here, we’ll take a look at some of the most common myths about prostate cancer, and separate fact from fiction.
Myth #1: Prostate Cancer Only Affects Older Men
While it is true that prostate cancer is much more common in older men, it is not true that it only affects men who are over the age of 65.
In fact, it is estimated that one in every six men will be diagnosed with prostate cancer during their lifetime, and many of these men will be younger than 65.
Myth #2: Prostate Cancer Is Always Aggressive
Prostate cancer is a highly variable disease, and not all cases of prostate cancer are the same. While some cases of prostate cancer are aggressive and require immediate treatment, many cases are slow-growing and may not require treatment at all.
In fact, many men will die of other causes before their prostate cancer becomes a problem.
Myth #3: Prostate Cancer Always Causes Symptoms
While it is true that some men with prostate cancer will experience symptoms, such as frequent urination, difficulty urinating, or blood in the urine, many men with prostate cancer will not experience any symptoms at all.
This is why regular prostate cancer screening is so important, as it can detect prostate cancer in its early stages, before symptoms develop.
Myth #4: Prostate Cancer Is Always Treated with Surgery or Radiation
While surgery and radiation are common treatments for prostate cancer, they are not the only options available. Depending on the individual case, other treatments, such as watchful waiting or hormone therapy, may be more appropriate.
It is important to work with a healthcare provider to determine the best course of treatment for your individual case.
Myth #5: Prostate Cancer Screening Is Not Necessary
There is ongoing debate among healthcare providers about the necessity of prostate cancer screening. Some argue that the risks of screening, such as false positives and unnecessary biopsies, outweigh the benefits.
However, many healthcare providers still recommend regular prostate cancer screening, especially for men with a family history of prostate cancer or other risk factors.
Myth #6: Prostate Cancer Is Always Fatal
While prostate cancer can be a serious disease, not all cases of prostate cancer are fatal. In fact, the five-year survival rate for prostate cancer is around 98%.
This means that the vast majority of men with prostate cancer will survive for at least five years after their diagnosis.
Myth #7: Prostate Cancer Is Linked to Sexual Activity
There is no evidence to suggest that sexual activity, including masturbation, ejaculation, or frequency of sexual activity, is linked to prostate cancer.
While some studies have suggested a possible link between sexual activity and prostate cancer, the evidence is not strong enough to draw any conclusions.
Myth #8: Prostate Cancer Is Caused by BPH
Benign prostatic hyperplasia (BPH) is a non-cancerous condition in which the prostate gland becomes enlarged.
While BPH can cause symptoms similar to those of prostate cancer, such as frequent urination or difficulty urinating, it is not a direct cause of prostate cancer.
Myth #9: Prostate Cancer Only Affects White Men
While prostate cancer is more common among white men than among men of other races, it can affect men of all races.
In fact, prostate cancer is the second most common cause of cancer death among Hispanic men, and the third most common cause of cancer death among African American and Asian American men.
Myth #10: Prostate Cancer Can Always Be Prevented
While there is no foolproof way to prevent prostate cancer, there are steps that men can take to reduce their risk. These include maintaining a healthy diet and exercise regimen, and avoiding tobacco and excessive alcohol consumption.
Regular prostate cancer screening can also help detect prostate cancer early, when it is most treatable.